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1 Introduction
The potential of synthetic biology is difficult to overstate. To be able to design
biosynthetic pathways to produce complex molecules cheaper, more safely, and
more environmentally friendly than current synthetic methods could open vast
possibilities both in science and industry. Unfortunately, much of this potential is
little more than an exciting dream, with concrete applications limited in scope and
lacking economic competitiveness, but this could be said of any nascent field in its
early days. One of the deficits in this field is the lack of knowledge about how
specific moieties are attached to their natural products, restricting the field to
protein systems that nature has already made modular and inhibiting efforts
toward more diverse structures. The purpose of this review is to examine one
broad type of moiety for which information is relatively lacking, sulfur containing
heterocycles. By highlighting what we know and what we don’t about this diverse
range of compounds, this review aims to serve synthetic biologists by informing
them what tools are at their disposal, as well as inform enzymologists and others
where there is opportunity to expand our knowledge in this area.
The review itself is broken into eight broad categories based on the structure
of the moieties discussed and then further subdivided into categories based around
classes of compounds when applicable and individual cases when not. A complete
examination of each compound’s biosynthesis would require far more than a single
review and therefore this review is focused on the incorporation of sulfur into the
compounds and the formation of the heterocycle. An effort has also been made to
mention those compounds that are likely to be produced through relatively novel
biological mechanisms, but have a deficiency of information on them.
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2 Disulfide Heterocycles
Figure 1: Metabolites with heterocycles containing a disulfide bond.
With bond energies on the order of 250 kJ/mol, disulfide bonds are
significantly less stable than the carbon carbon bonds that make up the bulk of
biological molecules.1 However, this bond is sufficient to stabilize compounds at
normal temperatures for most cellular environments, so long as they are in an
oxidative environment. Disulfide bond formation is metabolically favorable for the
cell to make often producing reducing equivalents that can be used in ATP
generation, or at most consuming ambient oxygen.2 Because of this disulfide bonds
are a common motif in protein tertiary and quaternary structures, especially in
excreted products.
While it is possible for a wide variety of cofactors to oxidize thiols in the
formation of a disulfide bond, the most common oxidant used in vivo appears to
be another disulfide bond formed within the thioredoxin motif CxxC,2,3 found on
2
Figure 2: General disulfide forming reaction.
an alpha helix positioned proximal to a flavin binding site. As shown in figure 2,
this placement allows the CxxC disulfide to be oxidized by the flavin, which then
transfers the two electrons either to NAD+ or O2 to regenerate the oxidized
enzyme for another round of catalysis. Four clades of disulfide forming enzymes
have been identified with sequence similarities consistent with the type of
substrates they oxidize, peptide oxidases like TrxR, epidithiodioxopiperazine 5
oxidases like GliT, dithiolopyrrolone 4 oxidases like HlmI, and DepH like
oxidases.4–6
3
Figure 3: Generalized peptide disulfide oxidizing system.
2.1 Peptide Disulfides
Disulfide bonds are often used in secreted enzymes to stabilize their structure. Ion
concentration, pH, and other conditions that determine a protein’s conformation
will vary outside the protective membrane of a cell, but it can reasonably be
expected that the environment will be oxidative enough to maintain a stable
disulfide bond. As disulfide bonds are used to stabilize large protein structures, it
is unsurprising that they are also used to form macrocycles in many secondary
metabolites, such as conotoxins, thionins, defensins, cyclotides and other short
polypeptides.7–11 Of these macrocyclic compounds, the most structural research
has been done on conotoxins.
No specific thioredoxin has been identified for any of the aforementioned
peptide products, each of which appear to use the same promiscuous oxidase as
larger protein disulfides. The most well studied systems are Ero1 and PDI in
eukaryotes, and the Dsb family of proteins in prokaryotes. Other peptide disulfide
oxidation systems have been identified,12 but no evidence has been published to
suggest that these alternitive enzymes play a significant role in the oxidation of
peptide secondary metabolites. As shown in Figure 3, these enzymes appear to
work in pairs with the soluble protein, PDI or DsbA, acting in the endoplasmic
lumen or the periplasmic space to oxidize the target. A membrane associated
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protein, Ero1 or DsbB, then reoxidizes the soluble protein and shuttles electrons to
an electron acceptor.2
As many of these metabolites have multiple thiols able to form disulfide
bonds, it is reasonable to expect that a promiscuous oxidase could catalyze
improper bond formation. Experiments involving rapid quench, limited oxidation
agent concentrations, and conditions that destabilize the substrate’s structure
confirm that improper disulfide bonds do form.10,13 However, improper disulfide
bridging is rare in fully oxidized products.10,11,13 It has been hypothesized that
partially oxidized products form an equilibrium between all possible bridges, with
formed bonds oxidizing reduced thiols in a series of intramolecular reactions.13
Proper bond formation appears to be cooperative,13,14 which is indicative of
thermodynamic control of proper bridging, since the most stable bridging pattern
will bring properly interacting sulfurs closer together, allowing for easier oxidation
by another oxidizing equivalent.10,14 Still, there do appear to be kinetic traps for
numerous peptide products, and it has been shown that PDI may help peptides
escape these traps by reducing improper bonds under certain conditions and
allowing the peptide to fold into a more stable confirmation.2,10,11,14
2.2 Epipolythiodioxopiperazines
The epipolythiodioxopiperazine 5 familly of compounds includes over a dozen
metabolites each containing a piperazinedione ring bridged by a disulfide bond.
The toxisity of this class of compounds seems to come predominantly from its
reduced form catalyzing the formation of reactive oxygen species (ROS).15–17
Epipolythiodioxopiperazines can also form covalent adducts with proteins,15–19
though the fact that this would involve the less toxic oxidized form of the
compound,5,15–17 and the lack of specific protein targets makes it unclear how
significant these adducts are for toxicity. The formation of the disulfide ring by the
producing organisms appears to serve two purposes. First it is protective,
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preventing the toxic compound from damaging the cell.20 Secondly it appears to
increase the lipophilicity of the compound. After leaving the producing cell the
disulfide is maintained by the surrounding environment so that it may enter the
target cells. Once inside the more reducing environment of the cytoplasm, the
epipolythiodioxopiperazine’s disulfide bond is reduced, making the compound
more hydrophilic. Unable to diffuse out of the cell after being reduced,
epipolythiodioxopiperazines accumulate in the target cells, enhancing the
compound’s toxicity.20,21 Paradoxically, a secondary function of
epipolythiodioxopiperazines 5 may be to protect cells from exogenous free radicals,
as demonstrated in A. fumigatus strains producing the
epipolythiodioxopiperazines 5 compound gliotoxin. A. fumigatus increased
gliotoxin production in the presence of hydrogen peroxide and gliotoxin mutants
showed greater susceptibility to hydrogen peroxide than the wildtype or mutants
with gliotoxin added exogenously.22
Figure 4: Epipolythiodioxopiperazines core formation.
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While recent work has advanced our understanding of many
epipolythiodioxopiperazines’ (5) biosynthesis,23–26 by far the most studied case is
the biosynthesis of gliotoxin (Fig 4), the first discovered
epipolythiodioxopiperazine 5 product.27 Epipolythiodioxopiperazines 5 exhibit a
moderate degree of diversity in their structures, but the core bicyclic rings are
highly similar. It is therefore likely that the biosynthesis of this core is conserved
within this class of compounds. In gliotoxin the piperazinedione ring 5 is formed
by a pair of coupling reactions catalyzed by GliP, a nonribosomal peptide synthase
(NRPS), between phenylalanine and serine to form a cyclic dipeptide.16,22,27 The
sulfur incorporation proceeds first by the activation of what was once the two
alpha carbons by a hydroxyl group, catalyzed by the monooxygenase GliC.22,28
This allows for the nucleophilic attack by glutathione, catalyzed by GliG, to form
the C-S bonds.16,27,29 GliK and GliJ then sequentially remove glutamate and
glycine from the glutathione appendage, respectively.30 The final cleavage of the
remaining cysteine is performed by GliI in a PLP-dependent reaction which
produces ammonium and pyruvate, and leaves a free thiol attached to the
piperazinedione ring.31
These thiols are oxidized by GliT, an FAD-dependent oxygenase that shares
a number of similarities to the thioredoxin family involved in peptide
maturation.16,22 A pair of cysteines shuttle the electrons to an FAD where they
can then be transferred to dioxygen (Fig 2).5,27 The use of oxygen instead of
NAD(P) as the final oxidant may be more energetically wasteful, but it drives the
reaction forward to minimize the quantity of potentially harmful reduced gliotoxin
in the cell.
2.3 Dithiolopyrrolone
The dithiolopyrrolone 4 family of antibiotics is defined by a bicyclic heterocycle
skeleton consisting of a pyrrolone ring decorated by an amino group, which is fused
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with a five-member disulfide containing ring.32 The family can be further
subdivided into holomycin type antibiotics if the pyrrolone amine group is
methylated, and thiolutin type antibiotics if it is not. For holomycin compounds
this methyl group appears to be attached after the dithiolopyrrolone ring 10 is
formed, as shown in Figure 5.33 Beyond this separation, further diversity is
acheived by the attachment of various acyl groups to the amino group.32,34–37 One
particularly notable variant is thiomarinol, which attaches the biologically active
marinolic acid to the amino group to form a hybrid antibiotic with higher activity
than either compound individually.38,39
Figure 5: Formation of the holothin dithiolopyrrolone core 10.
The enzymes shown in Figure 5 are from the holomycin biosynthetic
pathway. Homologs for the hlm cluster are found in all characterized
dithiolopyrrolone gene clusters. Hence, it is generally accepted that the
dithiolopyrrolone ring 10 is formed by the same mechanism in other
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pathways.33,36,38 The initial enzyme in forming the holothin ring 10 is HlmE, an
NRPS protein, which catalyzes the condensation of two cysteine molecules into a
dipeptide and then cyclizes the pyrrolone ring with help from the flavin dependent
acyl-CoA dehydrogenase HlmB. HlmB catalyzes the formation of a double bond
between the sulfur and the β-carbon of one cysteine to allow for nucleophilic
attack by the α-anion of the other cysteine.36 The formation of the dithiol bond to
close the second ring is catalyzed by HlmI. The active site of this protein is highly
similar to other disulfide forming enzymes, with two cysteines on an alpha helix
shuttling electrons to an FAD which then transfers them to a soluble electron
acceptor (Fig 2). Like GliT this electron acceptor appears to be oxygen, driving
the reaction in favor of disulfide formation.4,32,35,40
Dithiolopyrrolone antibiotics have been demonstrated to act by inhibiting
transcription, possibly by forming disulfide adducts with target proteins.32,35,40
The formation of the bicycle through oxidation of the disulfide bond appears to be
predominantly a resistance mechanism for the producing cell. Organisms lacking
HlmI exhibit significantly greater susceptibility,4 unless they possess an alternative
resistance gene such as an RNA methyltransferase found in Yersinia ruckeri.32,40
This strongly suggests that, like gliotoxin, holothin requires a reducing
environment to be active. The attachment of an acetate side chains to structure 4
accelerates non-enzymatic oxidation of the disulfide bond.4 This modification
probably helps to maintain the more lipophilic oxidized form of the compound in
the extracellular environment so, like gliotoxin, the compound can diffuse into the
target cells and accumulate in the more reductive environment.
2.4 Romidepsin-Like Compounds
Romidepsin (FK228) 9, thailandepsin, FR-901228, FR-901375 11, and
spiruchostatin (burkholdac) 12 are all histone deacetylase (HDAC) inhibitors of
similar structures and, presumably, similar biosynthetic mechanisms. Their
9
Figure 6: Example romidepsin-like compounds.
structures can be split into two primary components, a cyclic depsipeptide and a
hydrophobic four carbon tail ending in a thiol. This terminal thiol group is derived
from a cysteine, which is the starting unit for a PKS system responsible for
building the hydrophobic tail. This is then fed into an NRPS complex which
catalyzes the formation of the bulk of the compound. Which specific amino acids
are incorporated and whether an additional PKS system is used in the
depsipeptide moiety depends on the compound, but a cysteine is incorporated
early, either as the second or the third amino acid to be attached in the growing
peptide chain. This peptide chain is then cyclized to form the depsipeptide. This
is followed by disulfide bond formation between the two cysteine thiols to complete
the assembly of the bicyclic compound.41–44
Romidepsin 9 can be oxidized nonenzymatically by ambient oxygen,6 though
all identified biosynthetic clusters also contain an oxidase to accelerate the
process.43–45 The enzyme responsible for this final oxidation, DepH for romidepsin
9, is also similar in mechanism to GliT and HlmI, with a pair of cysteines
transferring electrons to an FAD and ultimately an oxygen (Fig 2).6,41,44,46 The
binding site for the oxygen has some of the features of an NAD(P) binding site,
but several amino acids appear to have been mutated to prevent NAD(P) binding
to this site. Notably Glu138, Ala197, Ser198 and Asp202, all hydrophobic or
negatively charged amino acids, occupy spaces that would be occupied by
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positively charged residues in NAD(P) binding proteins.46
The purpose of the formation of the bicyclic moiety is less clear in
romidepsin related compounds than it is in dithiolopyrrolones 4 and
epipolythiodioxopiperazines 5. The reduced form of romidepsin 9 has been
proposed to act by chelating the active site zinc ion of HDAC1 and HDAC2 using
the thiol at the end of the tail, with the depsipeptide cycle interacting with the
surface of the protein to provide a target specific plug for the channel.42,47,48 It is
also has been found that reduced romidepsin 9 can inhibit PI3K by binding to its
ATP binding pocket.48 However, the oxidized form has also been found to be more
active against HDAC3 than the reduced form.42 The negligible antibacterial
activity of romidepsin 949 makes it unlikely that there would be much pressure to
oxidize the compound as part of a resistance mechanism. It is likely that similar to
dithiolopyrrolones 4 and epipolythiodioxopiperazines 5, the oxidized form is better
able to accumulate in target cells, though there is no direct evidence to support
this hypothesis.
2.5 Lipoic Acid
Lipoic acid 7 is a cofactor vital to the activity of α-ketoglutarate dehydrogenase
(Fig 7), pyruvate dehydrogenase (Fig 25), branched chain oxo-acid dehydrogenase,
acetoin dehydrogenase, and glycine cleavage.50 It consists of octanoic acid with
sulfurs attached to carbons six and eight. The active cofactor is bound to lipolated
proteins through a peptide bond to a lysine residue on the target protein.51 The
cofactor alternates between a cyclic oxidized form, which allows it to undergo an
electrophilic attack by the newly decarboxylated α-anion equivelent, and a reduced
form after transferring the substrate to an acyl carrier protein (Figs 7). The
synthesis of lipoic acid 7 is unusual for two primary reasons. Unlike most cofactors
it is synthesized while attached to the target protein,51,52 and the sulfur source for
both thiol groups are derived from a protein associated iron sulfur cluster.53–55
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Figure 7: The role of thiamine and lipoic acid in the α-ketoglutarate dehydrogenase
complex.
Octanoic acid is attached to the target lysine of E2 by LplA, which is also
able to attach fully formed lipoic acid 7 to E2 that has been consumed from the
environment or recycled from degraded proteins.51 Once octanoic acid is bound to
E2 13 (Fig 8), LipA, which is also known as lipoyl synthase, is able to complete
synthesis by the insertion of both sulfurs (fig 8), consuming two molecules of SAM
in the process.50,52,56 Unlike most radical SAM enzymes, LipA contains two 4Fe-4S
clusters.56,57 One of these two clusters is part of a standard radical SAM domain
and is coordinated by three cysteines. It is used to reduce SAM in order to
generate 5′-deoxyadenosyl radicals (Ado•) for subsequent chemical reactions. This
cluster has been shown to interact with methionine in the crystal structure and a
channel to the surface provides possible access for ferredoxin reductase to reduce
the cluster after the reduction of SAM.57 In contrast the second 4Fe-4S cluster is
coordinated by a serine as well as the expected three cysteins. The purpose of this
serine in catalysis is unknown, but it is vital to sulfur incorporation into the new
12
product, though not for SAM consumption.53,57,57,58
Figure 8: LipA mechanism.
A crystal structure with octanoic acid bound to the iron sulfur cluster by one
covalent bond has been published (Fig 9). It occupies a small channel between the
two iron sulfur clusters and, in the crystal structure, either its binding or its
reaction causes the distance between the two clusters to contract from 15.3 Å to
11.8 Å, forcing the substrate and SAM into close proximity.53As shown in figure 8,
hydrogen from carbon six is abstracted by Ado• first52 and the resulting carbo
radical binds to a sulfur on the second cluster, forming a stable C-S bond with the
cluster.50,57,59 Presumably, after the methionine and the 5′-deoxyadenosine are
exchanged for a second molecule of SAM and the first cluster reduced, a second
hydrogen is abstracted from the C8 position.52 The crystal places this second
carbon a little over five angstroms from either of the available sulfurs,53
13
considerably closer than the 8-10 Å predicted by earlier computer modeling.57,58
After release of the finished product, it is unclear how the iron sulfur cluster is
regenerated. It is likely that the entire protein is unfolded by chaperones to allow
the iron sulfur cluster (ISC) system or another iron sulfur cluster generating
systems access to LipA’s active site.
Figure 9: LipA active site with octanic acid (light blue) bound to one of the two
Fe-S clusters. SAM has been cleaved to 5′-deoxy-Ado and Met (red)(PDB: 5EXK)
While LipA inserts both of the sulfurs that will form lipoic acids five member
heterocycle, it does not catalyze the formation of the heterocycle. This oxidation
is catalyzed by dihydrolipoamide dehydrogenase, also referred to as the E3
complex of its various systems.60 The reduced lipoic acid probably enters a 15 Å
channel formed by the dimeric protein to a disulfide motif positioned close to an
tightly bound FAD.60,61 As with other disulfie forming enzymes (Fig 2), electrons
from the lipoic acid are transfered to an internal disulfide, then to FAD, and
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ultimately to free floating NAD use in cellular respiration.60,61 Mutations
associated with E3 deficiency appear to predominantly affect dimerization,
cofactor binding, or the conformational structure of the substrate channel.60
2.6 Tropodithietic Acid
Phaeobacter inhibens has a complicated relationship with the marine algae with
whom it shares its environment. While the algae are actively growing this
bacterium will form a commensal relationship with it, protecting the eukaryote
from more aggressively pathogenic organisms. However, once the algae starts to
show signs of senescence P. inhibens will produce algaecidal compounds such as
roseobacticide to accelerate the demise of its one time partner.62 Before this
inevitable betrayal, P. inhibens aids its host by producing the antimicrobial
compound tropodithietic acid 6, and its tautomer, thiotropocin 15.63
Tropodithietic acid 6 is approximately 17-21 kJ/mol more stable than
thiotropocin 15, and the activation energy required to convert between the two
forms is about 8-33 kcal/mol.64 Tropodithietic acid 6 acts by shuttling protons
and other cations across membranes, collapsing the proton gradient.65 This
compound is produced by a number of species within the Roseobacter genus and is
significant both for its potential as a commercial antibiotic66 and for its current
benefit to aquaculture.67,68
The compound is synthesized from (Z)-2-9oxepin-2(3H)-ylidene-acetyl-CoA
13, a degradation product of phenylalanine.69 The six proteins responsible for
tropodithietic acid synthesis (Fig 10) do not appear to be present in the genome of
the producing organism, but rather on a low copy number plasmid maintained in
the population.68,70 The apparent sulfur source based on feeding experiments is
cystine, most likely with S-thiocysteine as an intermediate.71 The enzyme actually
responsible for sulfur incorporation is hypothesized to be TdaB, which attaches
the entire S-thiocysteine to compound 13. The S-S bond is then proposed to be
15
Figure 10: Proposed tropodithietic acid biosynthetic mechanism.
cleaved by TdaF. Two rounds of sulfur addition results in the formation of 14.
Neither TdaB nor TdaF have been extensively characterized and their proposed
activities are based on their homology to gamma-glutathione transferases and
phosphopantothenoylcysteine decarboxylases respectively.62,71 A dedicated oxidase
to close the disulfide heterocycle has not been identified. It is possible that the
bacteria depends on oxygen in the environment to oxidize this bond, but it would
be unusual compared to the production of more thoroughly studied disulfide
containing small molecule antibiotics, which all have dedicated oxidases to close
their heterocycles, as shown previously.
2.7 Asparagusic Acid
As the name would imply, asparagusic acid 3 has only been identified as a product
of Asparagus officinalis, better known as garden asparagus. The compound
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appears to be predominantly defensive, with clear anti-nematode activity and
possible anti-plant and insecticidal activity.72 Recently asparaptine, and apparent
adduct of asparagusic acid to lysine, has also been identified, though its role in
vivo and the enzyme responsible for attaching the amino acid remain a mystery.73
The carbon skeleton of this compound is derived from valine, and at least
one of the sulfurs is derived from cysteine, beyond that not much is known about
its biosynthesis.72 The enzyme responsible for the closing of the heterocycle is
asparagusate dehydrogenase, which use the electrons from the disulfide bond to
reduce NAD. Despite its clear similarity to lipoic acid 7, lipoyl dehydrogenase is
unable to reduce asparagusic acid 3, though asparagusate dehydrogenase can act
on both compounds.74
2.8 Under Researched Disulfide Heterocycles
Considering the propensity of thiols to form disulfide bonds in an aerobic
environment it may be presumptive to assume that a disulfide containing
metabolite always has an associated oxidase to close the cycle. However, the fact
that most examined compounds have an associated enzyme suggests that most
understudied compounds do as well.
Nereistoxin 1 was identified as a toxic component in the marine annelid
Lumbrineris heteropoda over half a century ago,75 and has been shown to inhibit
nicotinic acetylcholine receptors in higher organisms.76 The relative easy of
synthesis of nereistoxin 1 meant that there has not been much incentive to to
study the biosynthesis of the compound,77 particularly considering the relative
difficulty in studying multicellular metabolic compounds. Its similarity to
asparagusic acid 3 suggests the possibility of convergent evolution of defense
mechanisms that has not been seriously explored. Gerrardine 2 was isolated from
Cassipourea guianensis bark, and has been shown to have modest antibiotic
activity.78 Malformin 8 is produced by Aspergillus niger and related organisms
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and has both antibiotic and antimalarial activities, though it was originally named
for causing deformations in plant stems and petioles.79 It is clearly a cyclic
peptide, and based on the stereochemistry is probably produced via an NRPS,
though no associated genes have been identified. It is entirely possible that the
disulfide bond is produced by a promiscuous oxidase system like other disulfide
containing peptides. However, having only five amino acid residues, malformin is
about the same size as romidepsin 9, opening the possibility that its disulfide bond
is also oxidized by a dedicated oxidase.
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3 Monosulfur Macrocycles
Figure 11: Macroheterocycles with a single sulfur atom.
With bond dissociation energies on the order of 300 kJ/mol, thioether bonds
are somewhat more stable than disulfide bonds,1,80 and are significantly less likely
to be cleaved by reducing agents.81 They are also more difficult for the cell to
synthesize, requiring an activated carbon for the sulfur’s lone pairs to attack.
While thioethers are present in a wide variety of compounds, macrocyclic
compounds containing a thioether moiety are almost exclusively ribosomally
synthesized and post-translationally modified peptides (RiPP). Two types of
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thioethers have a well established mechanism of formation, the lanthipeptides,
which link cysteine to serine or threonine through a dehydration reaction followed
by electrophilic attack, and the sactipeptides, which link a cysteine to the
α-carbon of another residue through a radical SAM mechanism.
3.1 Lantipeptides
Figure 12: Lantipeptide defining moieties.
The best studied class of thioether containing RiPPs is the lantipeptides.
Containing over 100 members, lantipeptides are a diverse class of cyclic peptides
defined by the presence of one or more lanthionine 21 or methyllanthionine 22
moieties.82 This class is also commonly referred to as lantibiotics, though it is
unclear if all of these compounds are produced for the purpose of inhibiting
competition.83 Those that do act as antibiotics do so either by inhibiting protein
production, or by binding lipid II, inhibiting its use in producing peptidoglycan,
and aggregating to form membrane pores.84,85
As would be expected for RiPPs the sulfur source for these compounds is
cysteine, which is incorporated by the ribosome during the formation of the core
peptide. These residues are crosslinked to either serine or threonine by one of four
different classes of lantipeptide cyclase systems. The founding cyclase for these
classes are LanB and LanC for class I, LanM for class II, LanKC for class III, and
LanL for class IV.85–87 Each of these four classes appear to use a very similar
mechanism for the reaction, (Fig 13), though class I synthases use two separate
enzymes for the two required steps and the other three classes catalyze the
cyclizations with a single multifunctional enzyme.
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Figure 13: Overall mechanism of lantipeptide cyclases.
The first step is to activate the target hydroxyl group with a better leaving
group for elimination. Class I and II use glutamate, transferred from a charged
tRNA, while class III and IV use a phosphate group from ATP.88–91 This leaving
group is then eliminated by α-proton abstraction to form an electrophilic double
bond. This dehydration has been demonstrated to occur even in the absence of a
cysteine partner for the dehydroalanine to cyclize with.92,93 For class I compounds
this dehydrated compound is released from LanB at this point for further
processing by LanC. The cyclization is catalyzed by the activation of the thiol
group by a coordinated zinc, allowing it to perform a nucleophilic attack on the
dehydrated residue and forming the macrocycle.94–96 This mechanism appears to
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be the case for all lantipeptide cyclases, with the exception of class III cyclases.
LanKC lacks the motif for a coordinated zinc, and there is no evidence to suggest
that it binds through a non-canonical coordination sphere. How LanKC activates
the thiol group is still unknown.82
An attractive quality of the lantipeptide cyclases is the apparently generic
nature of the enzyme in its activity. RiPPs contain an N terminal leader sequence
that binds to the various enzymes which modify the core sequence. This ensures
that only the RiPPs will be modified, and not the other proteins within the cell.
Some RiPP modifying enzymes also recognize specific amino acid sequences to
direct their activity to specific residues, while others will modify every residue in
the core sequence that they are chemically able to. Lantipeptides are no exception,
and binding of a lantipeptide cyclase to the leader sequence determines which
peptides are cyclized.92,97 It seems likely that binding this leader sequence to
lantipeptide cyclases also causes conformational changes to activate the enzyme, in
addition to tethering the peptide to the protein.98,99 No peptide code directing
enzyme activity to specific residues in the core sequence have been reported,
though there does appear to be some optimization toward the peptide’s overall
structure in organisms that produce only one lantipeptide100. In general
lantipeptide cyclases appear to be fairly promiscuous toward the core sequences
they crosslink. Several organisms are capable of processing multiple peptides with
little homology between them using just one cyclase system.92,101,102 Even in
organisms with only one lantipeptide, the compounds often contain multiple
macrocycles with different flanking residues, all of which are processed by the same
protein.83,93
This promiscuity also leads to a question of how the proper lantipeptide
conformation is achieved, since despite having multiple possible linkages, only one
pattern of thioethers is observed for each peptide. The most likely reason for this
would be that the active conformation is the most thermodynamically stable. This
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explanation would require the enzyme catalyzed reaction to be reversible, as has
been observed for some lantipeptide cyclases.83,103 Cyclization down the length of
the lantipeptide appears to be directional, though which direction appears to
depend on the system. HalM2 for example works from the N terminus to the C,93
while ProcM works from C to N.83 Curiously, the rate of cyclization appears to
increase as HalM2 continues to act on the peptide, as would be expected if the
structure was moving toward a more energetically ideal conformation, but appears
to slow for ProcM. It has been proposed that the rational for this observation is
that since ProcM works on multiple lantipeptides, its active site has to
accommodate several different structures. As the lantipeptide’s structure is
restricted by the cyclizations it is less capable of interacting with the active site as
well as it could when it was more flexible, slowing later reactions. By contrast
HalM2 has only one substrate and can optimize its active site to accommodate the
final structure.100
3.2 Sactipeptides
Another class of thioether containing compounds that have received growing
attention recently are the sactipeptides. The family of compounds is defined by an
intrapeptide crosslink between cysteine and the α-carbon of the second amino
acid. At the time of this writing this small group only contains six RiPPs,
subtilosin A (22) (Fig 15),104 sporulation killing factor,105 six cysteines in forty
five (SCIFF),106 thuricin CD,107 thuricin H,108 and cyclothiazomycin,109 though
genomic mining for homologous proteins suggests the there are numerous
undiscovered members waiting for characterization.107
Biosynthesis of these RiPPs is an area of active research, but the thioether
crossbridging for all of the compounds appears to involve a radical SAM
mechanism (Fig 14). The 5′-dAdo radical abstracts a hydrogen from the target
α-carbon,110 the identity of this target does not appear to be catalytically
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Figure 14: Overall mechanism of sactipeptide cyclases. Dashed arrows show a
possible alternative mechanism.
important.111–113 This tertiary radical probably then forms a double bond with
either the keto or amino groups that then undergoes nucleophilic attack by the
thiol.114 It has also been proposed that the tertiary radical interacts with the thiol
directly.106 The thiol appears to be catalytically important to this reaction, since
neither serine nor methionine can replace cysteine in the sactipeptide.113–116
Most of the characterized crosslinking enzymes in this family contain
multiple [4Fe-4S] clusters, the exception being TrnC which contains only one
[4Fe-4S] cluster and catalyzes four of the six crosslinks in thuricin CD.117 In each
of these multicomponent clusters it has been demonstrated that all of the clusters
are necessary for protein activity, but only one is required for cleavage of
SAM.113,116,118 Two possible roles for the second cluster have been published. The
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first is that the cluster coordinates and oxidizes the cysteine sulfur, positioning it
to attack the α-carbon after 5 dAdo • activates it.119 The second theory is that
the cluster abstracts the unpaired electron from the peptide after 5 dAdo •
abstracts the hydrogen, forming an electrophilic center.114 AlbA and Tte1186a,
which crosslink subtilosin A 23 and SCIFF respectively, also contain a third
[4Fe-4S] cluster which is proposed to be involved in transporting the electron from
the second cluster to a soluble oxidant.106
Figure 15: Cross-linkage pattern of subtilosin A 23.
As with other RiPP treating enzymes, sactipeptide cyclases substrate
specificity is based on binding the leader sequence.112,113,116 At the intrapeptide
level, linking of cysteines with target residues seems to be based on the
sactipeptide’s tertiary structure. For subtilosin A 23, mutating the the
non-cysteine residue involved in the thioether bond has one of two effects. Most of
these mutations have no effect on the position of the thioether bonds, with the
new residue forming the same bond as the wild type residue would. A few of these
mutations disrupt either all three thioethers or both the C7-T28 and C13-F22
bonds, regardless of which bond was directly mutated.111 An unnatural subtilosin
A 23 analog that consists of residues 8-27 will not form the C13-F22 thioether,
but an analog that consists of residues 1-6 linked to residues 27-34 through a
peptide bond will form the C4-F31 thioether.114 This suggests that the outermost
linkage occurs first and that stabilizes the rest of the tertiary structure sufficiently
for the next bond to be formed, though more data is necessary to determine if this




Figure 16: A) Proposed mechanism of disulfide to thioether conversion in echino-
mycin 20 biosynthesis. B) methylation product of the reduced substrate.
Echinomycin 20, more archaically known as quinomycin A, is a quinoxaline
antibiotic that differentiates itself from others of its class by the presence of a
thioether bridge formed between two cysteine residues, bisecting the peptide
macrocycle. The gene cluster for this compound has been identified in various
strains,120,121 but at the time of this writing the compound itself appears to be
either unique or the founding member of a yet unidentified class of RiPPs, as no
other identified RiPPs contain the same dithioacetal bridge. The bridge is first
formed as a disulfide bond between the two cysteines by Ecm17, an FAD
dependent oxidase similar to the previously discussed DepH (section 2.4).
Afterwards, Ecm18, a radical SAM enzyme, converts the disulfide bridge to the
thioether.122 Determination of the crystal structure of Ecm18 with a
non-methylated intermediate has prompted a hypothetical mechanism for this
enzyme to be proposed (Fig 16 A). The conversion is initiated by the methylation
of one of the two sulfurs. This allows the deprotonation of the cysteine’s β-carbon
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and formation of a carbanion. This carbanion undergoes a nucleophilic attack of
the second cysteine, resulting in a rearrangement that forms the thioether and a
methyl sulfide. This mechanism is supported by the isolation of a monomethylated
product when a monocyclized (reduced dithiol) substrate is fed to Ecm18 in place
of the reduced bicycle (Fig 16 B).81
3.4 Indole Linked Macrocycles
Nosiheptide 17 is an RiPP antibiotic produced by Streptomyces actuosus.123 In
addition to the numerous thiazole rings, the formation of which will be discussed
in section 4, the compound contains an unusual indolic acid derived macrocycle
(Fig 17). The sulfur source for this heterocycle seems to be from cysteine
incorporated into the initial peptide. The tryptophan however is not present in the
core sequence and seems to be added separately to form the cycle. Research is
ongoing, but initial results suggest that an indolic acid 24 is loaded onto NosN by
the activity of NosI. NosK then transfered it to the cysteine side chain of the
thiopeptide. Once indolic acid is connected to the rest of the peptide, NosN will
catalyze both the methylation of the aryl ring and the closure of the macrocycle
within the substrate.110 This final enzyme is of particular interest as a radical
SAM enzyme which binds two equivalents of SAM at once, one is probably the
methyl donor while the other abstracts a hydrogen.110 While Figure 17 shows a
monomethylated indolic acid 24 being attached, it is unclear whether this
methylation occurs before, during, or after macrocyclization.124
While the enzymes involved are not as well researched, the amatoxin 18 and
phallotoxin 16 classes of compounds deserve some note here. Amatoxins 18 and
phallotoxins 16 are the compounds responsible for toxicity in the aptly named
death cap mushroom, or Amanita phalloides.125 Both of these toxins are RIPP
compounds126 with the primary differences being that amatoxins 18 are
octapeptides containing a sulfoxide thioether bridge, while phallotoxins 17 are
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Figure 17: Proposed mechanism of nosiheptide bicyclization. The process is shown
starting with a methylated indole 24 though it is unknown whether this methylation
occurs before or after the macrocycle is formed.
heptapeptides that use a sulfide thioether instead, both of which contain two
macrocycles.127 The larger cycle formed by a peptide bond between the first and
last amino acids in the peptide, catalyzed by a prolyl oligopeptidase type serine
protease.128 A smaller cycle is formed by a thioether bridge between the R groups
of a cysteine and tryptophan. The dissimilarities between the residues used to
form the thioether makes it unlikely to use the same mechanism as either
lantipeptides (Fig 13) or sactipeptides (Fig 14), and the fact that the indole is
clearly part of the core peptide makes a nosiheptide (Fig 17) like mechanism
equally unlikely. Unfortunately, the inability to culture producing fungi in the lab
has inhibited research into these compound’s biosynthesis, and the gene
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responsible for formation of these unique macrocycles remains unknown.
3.5 Trabectedin
Trabectedin 19, also refereed to as ecteinascidin 743, is a clinically useful
anti-cancer compound whose mode of action is inducing formation of double
stranded DNA breaks after binding to the minor grove.129 As a natural product
trabectedin 19 is exemplary of many of the challenges facing the field of
metabolomics. It is a relatively complex compound, consisting of three
tetrahydroisoquinoline moieties each with different individual modifications, and it
is produced by an organism associated with Ecteinascidia turbinate that cannot be
independently cultured in the lab. Metagenomics data has allowed researchers to
identify a likely gene cluster, despite being unable to obtain a pure culture of the
producing organism. It was also possible to confirm that the cluster’s genes are
translated into their protein products. Using the codon preferences of this gene
cluster they were able to identify Candidatus Endoecteinascidia frumentensis as
the most likely producing organism.130
One primary obstacle to this metagenomics approach is the difficulty in
expressing proteins heterologously to confirm their action. Most relevant to this
review is the lack of information concerning the thioether cycle in the product.
The sulfur source has been confirmed as cysteine by radiolabeled feeding
experiments,131 and this is consistent for the predicted amino acid substrates of
the NRPS protein EtuA3.130 The protein responsible for forming the thioether or
its mechanism of action however has yet to be determined.
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4 Thiazoles, Thiazolines, and Thiazolidines
Figure 18: Metabolites containing thiazole, thiazoline, or thiazolidine rings.
Thiazole rings are five member heterocycles including a sulfur, nitrogen, and
two double bonds. Reduction of one or both double bonds results in the formation
of thiazoline and thiazolidine respectively (fig 18). Thiazole and thiazoline are able
to participate in a diverse array of reaction, with two nucleophilic centers at the
nitrogen and sulfur and the carbon of the C=N bond able to act as an
electrophile.132,133 The greater aromaticity of thiazoles compared to other
heterocycles such as pyrrole or oxazole,134 allowing for cells to produce relatively
stable ring structures while still having lone pair electrons from the sulfur. As such
it should be unsurprising that biology makes use of these rings both as structural
elements and reactive centers.
Five different methods of forming these moieties can be said to be well
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understood, namely their incorporation into NRP, RiPP, Penam 24 products as
well as the formation of thiamine 26 in both eukaryotes and prokaryotes. For
NRPs, RiPPs, and penams 24 a cysteine thiol is activated by base or iron and
attacks a keto group of an adjacent peptide bond (Figs 19, 20, 23). NRP and
RiPP systems are particularly promiscuous in the peptide sequences they are able
to cyclize, while penams can only be formed from a tripeptide substrate,
L-alpha-aminoadipic acid-cystine-valine (ACV). Thiamine sulfurs are also derived
from cysteine, directly from the catalyzing enzyme in eukaryotes (Fig 28), and
indirectly from a thioacid carrier protein in prokaryotes (Fig 26).
4.1 Peptide Thiazoles, Thiazolines, and Thiazolidines
The variety of available amino acid side chains and the highly mobile amide
backbone of polypeptides allows for innumerous three dimensional structures to be
constructed from this polymer. In the face of such diversity it is unsurprising that
useful molecules, such as antibiotics and chelators, can be constructed from small
peptides. Unlike macromolecular proteins however, these peptides are usually
modified further, in order to restrict which conformations are favored to those
which are most useful for the producing organism. It would be impossible to
ensure the proper conformations of these small peptides using canonical residues,
since there are so few residues available to interact with each other.135,136 The
formation of a thiazole ring, or its oxidized varients, is common in peptides. These
pentameric rings help to form the proper coordination geometry around the target
ions in chelators,136–139 and can make antibiotics resistant to hydrolysis, improving
the effectiveness of antibiotics.140 Thiazolines and thiazolidine are particularly
useful in chelators due to their greater flexibility, allowing them to make fine
adjustments to better coordinate the target metals136
Two primary pathways exist for the formation of peptide metabolites
(Figs 19, 20). As discussed in section 3.2 RiPPs are formed in the ribosome using
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mRNA as a template, and then further modified by other enzymes. This mode of
biosynthesis usually has the advantage of greater variability and faster
adaptability, since modifications only require mutations in the gene encoding the
core peptide.137 In contrast, NRPs are formed through the action of dedicated
modular protein complexes reminiscent of PKSs, with each protein unit catalyzing
the addition of one specific amino acid to the growing chain. Because changes
involve the exchange of large subunits, it is more difficult to alter the sequence of
NRPs compared to RiPPs. However, NRPSs have the advantage of being able to
incorporate amino acids beyond the standard twenty into the growing polymer.141
Both of these systems use similar underlying chemistry to incorporate thiazoles
into the final compounds, but there are several key differences in the overall
processes.
The standard NRPS unit includes three subunits. An adenylation domain
which selects and activates the next amino acid, then transfers it to the
phosphopantetheine arm of the peptide carrier protein (PCP) domain. The
growing strand is transferred to the PCP domain when the condensation domain
forms the new amide bond between the growing strand and this new residue. The
PCP domain holds the peptide for more variable associated subunits to act on it,
before passing the peptide to the next step in the complex.142 The heterocyclase
domain, which forms the thiazoline moiety, has high sequence homology to
condensation domains, and can often replace them in the complex, acting as dual
activity condensase/heterocyclase enzymes. Despite its ability to replace
condensation domains, heterocyclase domains lack the HHXXXDG sequence
conserved in condensation domains. Instead they have a conserved DXXXXDXXS
sequence.143–145 After the thiazoline is formed, it can then be reduced or oxidized
to thiazolidines or thiazoles respectively by a separate redox protein.146–148
The mechanism for the formation of thiazoles (Fig 19) appears to be
identical to the formation of oxazoles in NRPs. It has been demonstrated that for
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certain systems, replacing the cysteine adenylase domain for a serine results in the
heterocyclase domain creating an oxazole.139,147 Although there has been some
indirect evidence suggesting that the initial bond formed by the heterocyclase
domain is a thioester,149 it is widely accepted that the first step in creation of an
NRP thiazole is the formation of a peptide bond. This is supported by the fact
that N900A and S984A mutations in MtaD, a duel condensation/heterocyclase
domain, was able to lengthen the polypeptide chain without the cyclization,
resulting in the presence of free thiols in the product.146 After the peptide bond is
formed a basic residue is proposed to deprotonate the thiol group of the cysteine,
making it a better nucleophile for attack on the α-carbon of the ketol group to
form the five membered ring. A second base removes a hydrogen from the
nitrogen, allowing the formation of a double bond and excluding a water
molecule.143,146 At first glance it seems likely that these basic residues involved in
catalysis could be part of the conserved DXXXXDXXS. This speculation has not
been supported by experimental evidence. Interestingly, the heterocyclase domains
of AngN (anguibactin),150 MtaD (myxothiazol),146 and EpoB (epothilone)140
could each loose either of their conserved aspartates and still produce the thiazole
containing product without any reported uncyclized peptides, though overall
production was significantly reduced. This suggests that the DXXXXDXXS motif
is either not the catalytic domain, or that there exists a redundant catalytic
residues in the subunit.
The thiazole/oxazole-modified microcins (TOMM) class of compounds are a
set of RiPPs that have oxazole and/or thiazole moieties added to the peptide
post-translationally.151 Like NRPS heterocycles, there seems to be a degree of
overlap in the activities of thiazole and oxazoles forming proteins, and some
heterocyclases are able to form both, though in these cases the thiazole rings are
formed more efficiently.137,152 Like all RiPPs the initial polymers are produced by
the ribosome in an unmodified form, meaning that unlike NRPs, the thiazole has
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Figure 19: Mechanism of NRPS heterocyclase domains.
to be added to a free-floating polypeptide. While a great deal of research has been
done on various TOMM compounds, the heterocyclase that has the most data
relevant to this review is the BalhC/D complex, involved in the synthesis of
TOMMs in Bacillus.
The heterocycle is formed predominantly by BalhD (Fig 20), with BalhC
improving its activity, possibly by better orienting the substrate in the active
site.153 As in NRPSs, the ring is most likely formed by a nucleophilic attack from
the thiol group against the ketol carbon of the N terminal amide bond. Unlike
NRPS heterocyclases, BalhC/D and related enzymes consume ATP in the process.
It is proposed that thiazoline formation is first catalyzed by a basic residue
activating the thiol group. This reversible reaction is driven forward by a
subsequent adenylation of the resultant oxygen anion by ATP. The reaction is
completed by the abstraction of a proton from the nitrogen, forcing the release of
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AMP as the thiazoline is formed.153,154
Figure 20: TOMM thiazole formation.
In addition to the catalytic mechanism, how RiPP modifying enzymes select
for the proper residues to modify is an important question. It is fairly clear that,
like other RiPP enzymes, the primary source of specificity for TOMM modifying
enzymes is the leader peptide, which often acts to anchor peptides to requisite
enzymes during processing,137 however the extent of the leader peptide’s
importance does not appear to be the same for all RiPPs. TruD for example has
been reported to be capable of specifically cyclizing one of its conjugate
trunkamides heterocycles without a leader peptide. This opens the possibility
that, in trunkamide’s case at least, the role of binding to the leader peptide
ensures processivity, but is otherwise not important to enzyme activity.155
There also appears to be specificity signals determining which residues
within the core peptide are modified. Microcin B17 processing, for example,
requires a glycine immediately before the cysteine or serine being cyclized.137
Thiocillin, patellamide, and various other TOMMs lack this signal, so it is clearly
not universal in the biosynthesis of TOMMs (Fig 21). In thiocillin, modification of
residues flanking cystine in thiocillin did not prevent natural cyclization. However,
cysteines added to the thiocillin core peptide failed to form a thiazole, suggesting a
specific signal in the core peptide that is not immediately N or C to the cyclized
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residue.156 These heterocyclization signals also appear to be independent of other
post translational processing, such as macrocyclization.155
Figure 21: Modified core peptides of TOMMs cited in this section and the structure
of the oxazole moiety for comparison, additional TOMM modifications not shown.
4.2 Penams
Discovered in 1928 by Dr Fleming, penicillin has not only saved millions of lives
directly as the first isolated antibiotic opened up fields of research which have
given us the variety of antimicrobial compounds which we enjoy today. Even with
such a long and prodigious history of research, study on penicillin biosynthesis
continues to yield interesting results to this day. Excluding the monobactam class,
all β-lactam antibiotics also contain either five or six-member ring fused to the
β-lactam.157,158 penam 25 and cepham antibiotics contain a thiol group in their
bicyclic core, and are therefore the two classes that will be discussed in this review.
β-Lactam antibiotics are named after the four membered amide heterocycle
necessary for their activity. This β-lactam moiety gives the compound very similar
conformation to the d-Ala-d-Ala found at the terminus of peptidoglycan’s
pentapeptide. This allows β-lactams to bind to enzymes that interact with this
dipeptide moiety,159 most notably the transpeptidases. Transpeptidase crosslinks
the strands of peptidoglycan in bacterial cell walls by first forming a covalently
linked intermediate with the tetrapeptide (the terminal d-alanine is displaced by
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the enzyme) and then forming a peptide bond between the remaining d-alanine
and an amino group on the lysine or diaminopimelic acid (DAP) functional group.
β-Lactams covalently link to the transpeptidase by the same mechanism as the
pentapeptide, but where the pentapeptides terminal alanine is displaced by the
enzyme, only the amide bond of the β-lactam bonds is disrupted. The resulting
acyclic adduct remains bound to the active site and the bulky side chains prevents
interaction with another pentapeptide, which would otherwise dislodge this
covalent adduct and release transpeptidase (Fig 22).160
Figure 22: A) Normal transpeptidase activity B) Mechanism of β-lactam transpep-
tidase inhibition.
Both penams 25 and cephams are synthesized through a common
intermediate, isopenicillin N (IPN) 31, by the enzyme IPN synthase (IPNS),161,162
which uses the cysteine derived thiol to form a ring in the mechanism (Fig 23).
Monobactams and carbapenems in contrast use a metal independent ATP
consuming mechanism to form their β-lactam moiety.157 IPNS is a non-heme
mononuclear enzyme that catalyzes the bicyclic ring formation through an
oxygen-dependent oxidation of an aminoadipoyl-cystein-valine (ACV) tripeptide.
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Four electrons are oxidized during the conversion of ACV to 31, producing two
molar equivalents of water and consuming one molar equivalent of dioxygen.163
Figure 23: Mechanism of IPNS.
Structurally as well as functionally IPNS is highly similar to the alpha keto
gluterate (AKG) dependent family of non-heme oxidases, with a core jelly roll beta
barrel motif coordinating the iron center.163 Specifically, His270, His214, and
Asp216 make up the 2His/1Carboxy motif used to coordinate the iron.163 Prior to
substrate binding this iron center is in a high spin state with octahedral geometry
and Gln330 occupies the space where the cysteine of the ACV substrate will bind,
coordinated through its side chain oxygen.164,165 Binding of ACV occurs before
oxygen coordination, with the cysteine displacing Gln330 at the position trans to
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His270.158,166,167 The aminoadipoyl and valine occupy hydrophobic pockets that
are fairly accepting of other hydrophobic moieties.168 It has been proposed that
Arg279 and Ser281 are important in coordinating the terminal carboxyl group of
the ACV substrate, preventing it from interacting with the iron center where it
would otherwise block oxygen binding.
The binding of the ACV substrate to the iron center through the thiol group
of ACV induces oxygen binding trans to Asp216 through two apparent
mechanisms. First, the thiol reduces the iron center from Fe(III) to Fe(II), making
it energetically more favorable for oxygen to bind.169 Second, the hydrophobic
valine side chain helps to displaces a water molecule from the apparent oxygen
coordination site around the iron by forming a hydrophobic pocket for the
oxygen.170 The binding orientation of ACV before and after oxygen binding is well
supported by crystallography using NO as a non-reactive homolog for O2.
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The peroxo formed from the oxygen binding to iron is proposed to abstract a
hydrogen from the β-carbon of the cysteine amino acid.171 This is one of two
partially rate limiting hydrogen abstractions as determined by deuterium kinetic
isotope effect (KIE) studies.168,172 The radical formed from this abstraction quickly
forms a nucleophilic double bond with the near by sulfur, temporarily breaking its
covalent bond with the iron center. The predominant theory is that the
hydroperoxo abstracts the proton from the nitrogen group on the valine, causing it
to undergo an electrophilic attack on the cysteine β-carbon, closing the β-lactam
and reestablishing the covalent bond with the sulfur. There is some confusion over
the closing of the β-lactam, as it has been shown that it is more favorable for the
hydroperoxo intermediate to abstract a proton from a nearby water rather than
the ACV nitrogen,169,171 but no good alternative base has been proposed in its
place to drive the β-lactam ring closure. The formation of the β-lactam ring and
subsequent formation of the iron IV oxo IPNS intermediate is supported by
computational modeling169 as well as the direct observation of a β-lactam
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intermediate in crystals.173
Regardless of what protonates the hydroperoxo, the result is an Fe(IV) oxo
species.174 This species is necessary for the otherwise unfavorable abstraction of a
hydrogen from the β-carbon of the valine, the second partially rate limiting
abstraction identified from KIE studies.168,172 This forms a tertiary radical on the
valine. This radical attacks the cysteine sulfur, closing the five member ring and
displacing the bond with the iron, allowing for the IPN 31 to dissociate from the
enzyme.162,168
Figure 24: Products of d-α-aminobutyrate containing substrate.
The generation of a radical in this final step has been confirmed through
various reactive analogs of valine. IPNS has shown an ability to accept a variety of
hydrophobic valine analogs in the ACV substrate, as well as a surprising lack of
specificity in where it generates the carbon radical.162,168,170,175 Replacement of
valine with d-α-aminobutyrate generates both R and S stereochemistries for the
resulting penam 31 in an approximate ratio of 1:7 (R:S ) (Fig 24).170 This
experimentally supports the loose binding of the valine observed in the crystal
structure, where the abstracted hydrogen is oriented away from the iron ion center
upon the initial binding of ACV and then must rotate around to point the
hydrogen toward the center once NO has bound. More surprisingly, this analog
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also generates a cepham product in a ratio of 3:8 cepham to lactam.170 This
suggests that the iron (IV) oxo species is capable of generating a radical on any of
the three carbons in the valine but only abstracts from the β-carbon primarily
because of the relative stability of the tertiary radical. Thus, the β-radical it is the
only catalytically relevant radical, as opposed to selectivity being determined by
substrate orientation by the enzyme.
4.3 Thiamine
Figure 25: Thiamine’s mechanism in pyruvate dehydrogenase.
Thiamine 27 is a cofactor involved in the transfer and removal of carboxyl
groups across all domains of life, and is vital for the metabolism of amino acids
and carbohydrates in the cell.176 The thiazole 27 acts as the point of attachment
for substrates, with the aminopyrimidine likely acting as a base to directly or
indirectly activate the thiazole 27 by forming the nucleophilic ylide (Fig 25).177
Thiamine 27 is produced by numerous species of bacteria, fungi, plants, and
archaea, however mammals have lost the ability to produce the compound and
must obtain it through their diet.178,179 While thiamine 27 has the distinction of
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being the first identified vitamin, discovered by Dr. Suzuk in 1935,180 it hasn’t
been until the early part of the twenty first century that the biosynthetic pathway
has been pieced together. The thiazole and pyrimidine heterocycles are
synthesized separately before being linked together to form thiamine. As this
review is focused on the formation of thioheterocycles, only the formation of the
thiazole phosphate carboxylate 34 component will be discussed.
Figure 26: The mechanism of thiazole phosphate carboxylase 34 biosynthesis in
prokaryotes.
In all bacteria where thiamine synthesis has been studied, predominantly
Escherichia and Bacillus species, the formation of thiazole phosphate carboxylate
34 involves the activity of six proteins acting to combine sulfur, deoxy-d-xylulose
phosphate 32, and dehydroglycine 33 (Fig 26).181 The first step for sulfur
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incorporation is the loading of a thiol group onto the C terminus of ThiS. This is
catalyzed by ThiF, which forms a surprisingly stable complex with ThiS to
adenylate its C terminus prior to thiol donation by a cysteine desulfurase.181–187
The most commonly used cysteine desulfurase identified in this reaction is the
promiscuous IscS, though it has also been shown that many organisms have
redundant cysteine desulfurases, such CdsH in Salmonella enterica, that can be
used to load ThiS.188,189 ThiG is the primary enzyme catalyzing the formation of a
thiazoline phosphate carboxylase 34 product from deoxy-d-xylulose-5-phosphate
32, dehydroglycine 33, and the thiolated ThiS.178,181,183,184,190 The
deoxy-d-xylulose-5-phosphate 32 used by ThiG is synthesized from pyruvate and
glyceraldehyde-3-phosphate by Dxs, while the dehydroglycin 33 can come from
various sources, depending on the organism and environmental conditions. In
Bacillus subtilis a glycine is dehydrated by ThiO to form dehydroglycin 33, while
in E. coli under anaerobic conditions a tyrosine is degraded by the radical SAM
ThiH to generate the two carbon compound.181,190–192 A reasonable intramolecular
mechanism for ThiG has been proposed and is supported by numerous
experiments and the crystal structure,180,193 though the final cyclization step still
requires confirmation. The sugar is bound to the enzyme by Lys96 at C2.183 This
induces an Amadori-type rearrangement, converting the alcohol at C3 to a
carbonyl.194 This allows a nucleophilic attack by ThiS to deposit its thiol at the
C3 position, displacing the oxygen. The dethiolated ThiS then undergoes a S→O
acyl migration to C4 before being releases to be reloaded with another thiol.183,184
This thiol can then attack the dehydroglycine at C2. The last step is the
displacement of lysine 96 by the dehydroglycine amino group, closing the
heterocycle and releasing the enzyme. The thiazoline ring can then tautomerize
nonenzymatically into the requisite thiazole, though TenI usually accelerates the
tautomerization in vivo.179,195
In contrast to the prokaryotic system, to make thiazole phosphate
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Figure 27: The iron independent Thi4 reactions.
carboxylate the eukaryotic/archaeal system requires just one protein, Thi4, and
two substrates, dehydroglycine 33 and NAD+ 35 to form thiazole phosphate 34
carboxylate (Figs 27, 28).176 Thi4 is an iron-dependent enzyme which forms
octameric complexes in solution.196 The protein also has what appears to be a
degenerate FMN binding site, though no one has found FMN in the protein and
the structure suggests that it would be impossible for the cofactor to bind.197
The Thi4 reaction begins with the hydrolysis of NAD 35 to remove the
nicotinamide moiety.198 A dehydroglycine 33 is then added to the freed sugar
moiety through a dehydration reaction.198 Another dehydration reaction removes a
hydroxal group concurrent with sulfur attachment. The exact mechanism of
heterocycle closure has yet to be confirmed, though reasonable mechanisms have
been proposed (Fig 28).179,196 Hydrolysis of the diphosphate linker with the
adenosine leaves thiazole phosphate carboxylate for further reactions.179
With so many different reactions catalyzed by one enzyme it is no surprise
that Thi4 remains an enzyme of interest. Primary work in recent years has focused
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Figure 28: The iron dependent Thi4 reactions.
on the sulfur source for the enzyme and the role of iron in the reaction. The
incorporated sulfur for most Thi4 homologs has been identified as Cys205 of the
Thi4 protein, making it a suicide enzyme in vitro. The resulting dethiolated
residue appears to form a thioether with the adjacent Cys204.199,200 Whether this
cysteine can then be regenerated, or Thi4 is a single use cosubstrate has yet to be
conclusively demonstrated. Several archaeal organisms found in environments with
high hydrogen sulfide concentrations appear to use ambient hydrogen sulfide as the
thiol source and have replaced this otherwise vital Cys205 with a serine.196,201 It
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has also been found that S. cerevisiae C205S Thi4 mutants consume hydrogen
sulfide and no longer acts like a suicide enzyme in vitro.196
The role of iron in Thi4 activity is another area of active research. The ion
appears to be a transient feature in the enzyme structure, coordinated by the
substrate, an aspartate, and a histone residue. Once coordinated it appears to
activate the sulfide to allow it to attack the ketol group and attach to the
substrate. It has been proposed that the iron then dissociates from the complex to
allow the rest of the cyclization to proceed (Fig 28).196,199,201
4.4 Firefly Luciferin
Figure 29: Light producing luciferin cycle.
Many a poet has written on the beauty of fireflies flying on a warm summer
night. In addition to their atheistic value, firefly luciferase has also been a valuable
tool for numerous biological assays. Fireflies are not the only organism to produce
light, collectively the enzymes responsible for bioluminescence are referred to as
luciferases, and the molecules they act on, luciferins.
Firefly luciferin 26 is the only one of these diverse molecules that contains a
sulfur heterocycle, and therefore the only one that will be noted. Firefly luciferin
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Figure 30: Luciferase catalyzed light producing reaction.
26 contains both an thiazole and a thiazoline moiety in its structure, but beyond
data showing that the compound is constructed from two d-cysteins and a
p-benzoquinone the biosynthetic pathway remains unknown.202 The light emitting
reaction involves the peroxidation of the thiazole through a carbanion intermediate
(Fig 30). A single electron transfer mechanism to circumvent the spin forbidden
process of binding the oxygen directly to the carbanion.203 This results in a
decarboxylation of the luciferin 26 and the gereration of an excited oxyluciferin 36
which rapidly decays to the ground state 37, releasing a photon.204 The thiazoline
ring serves to initiate the breaking of the oxygen-oxygen bond by donating a
partial negative charge to initiate the dissolution of the bond.204 After the
chemical’s photon emitting reaction, the thiazoline is degraded and the sulfur
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removed as part of thioglycolic acid (Fig 29). This moiety can then be regenerated
by the nonenzymatic reaction of d-cysteine with the cyano group of
2-cyano-6-hydroxybenzothiazole 38.205 No work examining the possibility of an
enzyme to accelerate this reaction have been published.
4.5 Understudied Thiazole Compounds
Despite the relative simplicity of the motif there are several thiazole and thiazoline
compounds that have little more known about their biosynthesis than what
organism produces them. Dercitin 30 is a compound isolated from Dercitus sea
sponges that exhibits anti-tumor activity. It works by intercalating the DNA,
similar to other pyridoacridine antibiotics.206,207 S1319 28 is a Dysidea sponge
product. It is a β2-adrenoceptor agonist and has been shown to inhibit IgE
mediated mast cell activation.208,209 Violatinctamine 29 comes from the tunicate
Cystodytes cf. violatinctus, and was identified in a comprehensive secondary
metabolite screening effort.210 One of the challenges of studying the biosynthesis
these compounds is that they are produced by multicellular organisms, which are
both more difficult and expensive to study than bacteria. To further complicate
things, it is difficult to determine which secondary metabolites isolated from
Porifera and Tunicate sources are actually produced by their normal flora.
Microbes associated with these organisms are notoriously difficult to isolate in
pure culture, inhibiting direct study of their metabolic pathways.211,212
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5 Cephams and Other Six Member Heterocycles
Figure 31: Metabolites with six member heterocycle rings.
5.1 Cephams
Like penams 25, cephams 40 are beta lactam antibiotics with a fused
biheterocyclic ring system, where the larger ring contains a sulfur. As may be
predicted by their similarities, the two antibiotic families share the same early
biosynthetic steps, branching into different pathways after IPNS makes the beta
lactam ring (Fig 23). After IPNS, penam 25 antibiotics add diversity by
modifying the side chains attached to the bicyclic core of IPN, cephams 40 by
contrast expand the five member sulfur containing ring to a six member ring
before diversifying the side chains (Fig 33).213 The enzyme involved in this ring
expansion is often referred to as penicillin N expandase, especially in the early
literature. It is now more common to find it referred to as deacetoxycephalosporin
C synthase (DAOCS) in the literature. The conversion of penicillin N to
cephalosporin C is by far the most favored conversion for the enzyme, but in vitro
DAOCS can also catalyze the ring expansion of other penams 25, though at
severely reduced efficiencies.214 DAOCS, like IPNS, is an iron dependent non-heme
monooxygenase, specifically an AKG dependent oxygenase. Unlike IPNS this
enzyme is functionally, as well as structurally, a member of the AKG oxygenase
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family, using two electrons from AKG to produce the iron IV oxo species necessary
for activity.215,216
Figure 32: Crystal structure of DAOCS (green) with both penicillin G (dark red)
and AKG (light blue).
There is some ambiguity as to whether this enzyme’s mechanism is analogous
to others of the same family. Crystallography of DAOCS bound to either penicillin
N or AKG show the two substrates coordinating around the iron atom occupy the
same space (Fig 32), suggesting that the AKG is released from the iron center
after donating its two electrons.217,218 Mass spectroscopy, NMR, and UV
experiments using the soluble form of the enzyme support the canonical
mechanism of AKG and penicillin N binding at the same time.219 This would
suggest that a crystallization artifact caused AKG, penicillin N, or both to bind
improperly, however the crystals have been found to be catalytically active upon
soaking with the substrate,217 suggesting that any artifacts present are minor.
Regardless of whether penicillin N can bind concurrently with AKG, the vast
majority of papers accept that the reaction occurs through what is referred to as a
Morin rearrangement (Fig 33).219 In this mechanism, the iron IV oxo substrate
abstracts a hydrogen from the pro-R methyl on the five member ring, forming a
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Figure 33: Cepham ring expansion mechanism.
primary carbon radical. This radical forms a double bond by breaking the
carbon-sulfur bond of the larger ring. This electrophilic double bond then interacts
with the nucleophilic thiol group to expand the ring into a hexameric cycle. This
bond forms a tertiary carbocation that is resolved by the formation of a double
bond accompanied by the abstraction of a hydrogen from the proximal carbon.220
A significant amount of work on DAOCS has been focused on developing
enzymes capable of accepting penicillin G as a substrate in place of the more
expensive and less stable penicillin N. The native enzyme has surprising specificity
toward penicillin N, even over the IPNS product, isopenicillin, which only differs in
the stereochemistry of the end of the α-aminoadipic acid moiety. Penicillin N has
the R stereochemistry, while isopenicillin N is S. Thus far the most effective
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modifications to improve penicillin G activity are localized in the C terminus, as
would be expected from the crystal structure.221,222
5.2 Understudied Compounds
For an antibiotic that was discovered approximately four decades ago,223 there is
surprisingly little known about the biosynthesis of chuangxinmycin 41. Recent
discovery of similar compounds in the producing strain, Actinoplanes tsinanensis,
may serve to shed light on the compound’s biosynthesis, but at this time it is
unclear whether such compounds are intermediates or variations of the
antibiotic.224 7-Hydroxy-5-hydroxymethyl-2H-benzo[1,4]thiazin-3-one 39 by
contrast was discovered relatively recently in Ampelomyces.225 Future work on this




Figure 34: Cruciferous phytoalexins with sulfur containing heterocycles.
Phytoalexins are small molecules produced by plants in response to stress,
generally bacterial or fungal attack, but also in response to the presence of heavy
metals or an excess of UV radiation.226,227 As would be expected for a class of
compounds defined by their function there is a lot of molecular diversity within
the classification, but within this diversity there are numerous groups which share
structural similarities. Relevant to this review are the phytoalexins produced by
the agriculturally important Brassicaceae family of plants, archaically known as
Cruciferae.
Cruciferous phytoalexins predominantly consist of a tryptophan derived
indole with a sulfur bearing moiety, often a heterocycle, bound at carbon three.
There have recently been identified several phenylalanine derived cruciferous
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phytoalexins, namely the nasturlexins 42,228,229 which also contain sulfur bearing
heterocycles. Although a biosynthetic pathway for these phenylalanine derived
heterocycles have been proposed, the lack of data to support this hypothesis makes
it difficult to do more than mention them.
The diversity of these compounds and the conditions that stimulate their
production suggests multiple mechanisms of action. Unfortunately the specifics of
cruciferous phytoalexin activity have not been well studied.230 Membrane
disruption in bacteria is the most well established mode of action in examined
compounds, but the mechanism of this disruption and the role of sulfur in the
process is unknown.231 Less relevant to the plant, but more relevant to medicine,
several cruciferous phytoalexins have anti-proliferative affects. For camalexin 43
this anti-proliferative activity appears to be mediated by the generation of reactive
oxygen species.232
As is often the case, the size and complexity of most plant genomes, and the
lack of obvious organization, has made it difficult for researchers to determine the
biosynthetic pathways of these compounds. Many of these phytoalexins appear to
be derived from brassinin,233–237 though how sulfur gets incorporated into
brassinin has yet to be determined. It has been demonstrated that S-tryptophan
53 is a precursor of brassinin 52,238 and that the sulfur source is either cysteine
directly, or a cysteine derived compound.239 While there remains a great deal of
work, recent papers have shed some light on the biosynthesis of camalexin 43,
theindolin 47, spirobrassinin 49, and cyclobrassinin 48.
From brassinin 52 the P450 monooxygenases CYP71CR1 and CYP71CR2
can form spirobrassinin 49 and cyclobrassinin 48 respectively (Fig 35). The
proposed mechanism for these two cyclizations is the formation of an epoxy ring
with C2 and C3 of the indole, the following nucleophilic attack by sulfur forms the
five or the six-member ring.234 At least two variants, sinalbin B 45 and erucalexin
50, are proposed to follow the same mechanism using a different precursor, namely
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Figure 35: Proposed pathway for brassinin and derived products.
1-methoxybrassinin.235 This theory cannot be confirmed however, until sinalbin B
45 and erucalexin’s 50 biosynthetic enzymes are identified.
The minimal set of necessary enzymes for camalexin 43, the predominant
phytoalexin produced by Arabidopsis thaliana, have also been determined
(Fig 36).240,241 The initial steps of production from tryptophan requires two P450
cytochrome catalyzed oxidations, an oxidative decarboxylation performed by
CYP79B3 or by CYP79B3 followed by a second oxidation by CYP71A13 to form
indole-3-acetonitrile 54.240,242,243 The sulfur incorporation step that comes next
appears to have several redundant mechanisms. The primary rout in vivo is the
attachment of glutathiol by GSTF6 followed by the cleavage of the glutamate and
glycine by GGP1 or GGP3 and carboxypeptidase respectively.244,245 GH3.5 has
also been found to be able to attach cysteine directly to indole-3-acetonitrile 54,
though with lower activity.246 The attachment of the thiol is thought to be
preceded by the activation of the target carbon by a hydroxyl, and it has been
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Figure 36: Proposed pathway for camalexin 43 biosynthesis.
found that CYP71A13 is able to hydroxylate the necessary site, though it is
unclear if this activity is significant in vivo.240 Regardless of how the cysteine is
attached, the cyclization is catalyzed by CYP71B15, a third P450 that also
catalyzes the final oxidative decarboxylation in camalexin 43 biosynthesis.240,247
The chemistry for these proteins appears fairly conventional, so it is not terribly
surprising that no work has been published examining the specific mechanisms of
sulfur incorporation or cyclization.
The minimum set of enzymes involved in production of thienodolin 47 have
been identified by heterologous expression in a non-producing strain, and a
reasonable pathway has been proposed.174 Unfortunately for this paper, the focus
has been on halogen rather than sulfur incorporation or heterocyclization, and
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these steps have yet to be examined in detail.
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7 Thiosugars
Figure 37: Heterocycle forming thiosugars.
Little is known about the incorporation of sulfur into thiosugars in general,
much less those few thiosugars that form heterocycles. Kotalanol 57, ponkolanol
58, salacinol 55, and salaprinol 56 are all extracted from Salacia speicies as part
of Ayurvedic traditional medicine to treat diabetes.248–251 Tagetitoxin 59 is an
RNA polymerase inhibitor produced by Pseudomonas syringae that shows activity
against bacteria, chloroplasts, and eukaryotes.252 While the structure has been well
established for all of these compounds, almost nothing is known about how they
are produced in vivo.
Of all the heterocyclic thiosugars, the most research has been published on
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Figure 38: Sugar moieties with biosynthetic enzymes homologous to enzymes in the
albomycin gene cluster.
the biosynthesis of albomycin 60. This antibiotic uses a Trojan horse strategy in
order to gain entrance to its target cell. The chelator moiety entices the cell to
take it up into the cytoplasm, where the modified 4-thiofuranosyl cytosine moiety
it cleaved off by native proteases.253 The freed thiosugar can then inhibit
seryl-tRNA synthases.253,254 These functionally different moieties are also
synthesized through two independent pathways before being joined by AbmR and
AbmC. The chelator is formed from N5-aceyl-N5-hydroxyornithine by a fairly
standard NRPS pathway, while much less is known about the thiosugars
formation.253 Inducing cysteine and homocysteine production in the cell also
increases albomycin production, supporting the hypothesis that those compounds
are at least indirectly incorporated into the thiosugar.255 Based on homology to
enzymes in the caprazamycin 61 and A-90289 62 biosynthetic pathways, it has
been proposed that AbmD, AbmF, AbmH, AbmJ, and AbmM are involved in the
thiosugars formation.253 However, neither caprazamycin 61 nor A-90289 62
contain a thiosugar themselves, limiting the ability to propose reasonable detailed
59
pathways without further information.
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8 Polythiol Rings
Figure 39: Heterocyclic products with more than two sulfurs.
For those natural products with more than two sulfurs in their heterocycles
it is often difficult to differentiate intended products from isolation artifacts or
minor side products, especially when there is so little data available on the
compounds’ biosynthesis. Indeed, lenthionine 63 is the only polysulfide
heterocyclic metabolite with solid evidence to support direct enzymatic
involvement. 1,2,3,5-Tetrathiane-5,5-dioxide 64 was identified from a screen of the
red alga Chondria californica’s products.256 Varacin 62 was isolated from
Polycitor species and Lissilinum tunicates, and shows thiol mediated cleavage of
DNA.257,258 Several cytotoxic lissoclibadin 66 compounds have been isolated from
Lissoclinum cf. badium, some of which contain sulfur heterocycles, and some of
which do not.259,260 Cassipoureamide 65 is found in Cassipourea guianensis wood
and appears to have an insecticidal function.261
Lenthionine 63 is produced by the fruiting bodies of the Lentinula edodes
fungus, better known as shiitake mushrooms, as well as the marine bacteria
Roseobacter denitrificans.262 While this compound has modest antibiotic activity, it
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is far better known for the aroma and flavor it imparts on the edible mushroom.263
Despite being isolated in 1966264 there remain numerous questions about the
synthesis of the compound, even to what extent its formation is enzymatic.263 It
has been established in the 1960s and 1970s that lenthionine’s 63 formation from
its precursor, lentinic acid,265 requires at least a cysteine desulfurase266 and a
glutamyl transpeptidase267 from the producing mushroom. From this point
research as to lenthionines 63 biosynthesis has been for the most part stagnant. A
recently identified but poorly characterized cysteine desulfurase, Lecsl, encoded by
L. edodes may play a role in lenthionine biosynthesis. Phylogenetically, this PLP
dependent enzyme fits poorly with previously identified cysteine desulfurases,
forming its own third clade of cysteine desulfurases. Functionally, it is unusual
since it is more efficient in cleaving the C-S bond in S-methyl-l-cysteine sulfoxide
than in l-cysteine.268 While the Lecsls role in lenthionine production has not been
directly examined yet, it is consistent with the enzyme that was demonstrated to
be involved in lenthionine production in 1971.266,268
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9 Miscellaneous Heterocycles
Figure 40: Heterocyclic products that do not fit into any of the previous sections.
9.1 Caldariellaquinone
Caldariellaquinone 70 appears to be an unusual electron carrier found in the
acidothermophilic genus Sulfolobus. The compound was first identified in 1977. It
has been confirmed that the electron carrying head group is derived from tyrosine,
and that the tail is constructed from isoprene monomers.269–271 How the sulfur is
attached or how the pentameric heterocycle is closed remains a mystery.
9.2 Leinamycin
Leinamycin 69 is a PKS/NRPS derived broad spectrum antibiotic produced by
Streptomyces atroolivaceus. The compound contains two heterocycles, a thiazole
whose formation is similar to what has been previously discussed, and a
1,3-dioxo-1,2-dithiolane moiety which is significant for its anti-tumor and broad
spectrum antibacterial activity.272,273 The disulfide bond in the molecule can react
with O2 to generate reactive oxygen species and the reduced thiols can covalently
modify guanine in the DNA.274
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Figure 41: Sulfur incorporation into leinamycin.
The formation of this disulfide containing ring is an area of active research
(Fig 41). While many of the components of the five-member ring appear to be
added while the compound is bound to the final PKS complex, only one carbon of
the five-member ring comes from the canonical PKS chain extension. The other
three carbons are derived from a methylmalonyl moiety whose attachment and
decarboxylation are catalyzed by the joint activity of LnmL, LnmK, LnmM, and
LnmF.275 The more proximal sulfur is derived from cysteine. It is most likely
attached to the polyketide product by an as of yet uncharacterized domain of the
LnmJ PKS domain. The attached cysteine is then cleaved by the recently
characterized cysteine lyase domain of the same LmJ. This domain has been
confirmed to break the C-S bond of cysteine in a PLP dependent manner without
much specificity toward what else is attached to the sulfur.272 Unfortunately, the
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process to attach the second sulfur is currently unknown, as are the proteins which
oxygenate and oxidize the disulfide bond.
9.3 Biotin
Biotin 67 is an essential cofactor involved in carboxylation within every domain of
life (Fig 42). The catalytically important moiety consists of a ureido ring fused to
a sulfur containing thiophane ring. This ureido moiety is covalently attached to
enzymes by the activity of BirA through a fatty acid chain linked to the five
member heterocycle. Crystal studies have shown that in the protein the urido
sulfur interacts with lysine and/or the aeromatic ring of tyrosine,276,277 possibly
serving to better align the bicyclic ring. Outside of the enzyme, the sulfur
component of biotin has been shown to decrease the pKa of both urido nitrogens
when compared to O-heterobiotin, facilitating the cofactor’s carboxylation.278
Despite its necessity, humans and other animals have lost the ability to
produce biotin 67, and depend on intake from their diet and from biotin
producing organisms in the gut to fulfill their required intake of the cofactor. The
high prevalence of biotin 67 in most foods, the ease of recycling biotin 67 cofactor,
and the exceedingly small quantities required clearly did not provide much
evolutionary pressures for animals to maintain a biotin producing pathway,
especially considering the unusually high energy cost. Biotin’s 67 biosynthetic
pathway contains two unusually high energy steps. First, a transaminase reaction
catalyzed by BioA uses SAM as a nitrogen source instead of glutamate or some
other amino acid. This reaction isn’t directly expensive for the cell, but the
deaminated SAM spontaneously degrades, requiring the cell to spend energy
replenishing its supply. The second unusually energetically demanding step is in
forming the ureido ring using an iron sulfur cluster as the sulfur source.279
The enzyme responsible for the last step of biotin 67 biosynthesis is the
homodimeric protein BioB, also referred to as Biotin Synthase. Within it, two
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Figure 42: Pyruvate carboxylase mechanism.
molar equivalents of SAM are converted to Ado and methionine and one of its two
iron sulfur clusters are degraded to produce a molar equivalent of biotin 67
(Fig 43). The first SAM is oxidized by a [4Fe-4S] cluster, generating dAdo•.280–282
This radical abstracts a hydrogen from C9 of dethiobiotin (DTB) 71, allowing it
to attack a [2Fe-2S]2+ cluster, covalently bonding to the µ sulfur.280–285 This
9-mercapto DTB 72 is then held in the active site while dAdo and methionine are
exchanged for a new SAM and the [4Fe-4S]2+ cluster is reduced by a ferredoxin
reductase back to [4Fe-4S]+.279,286,287 The second dAdo• abstracts a hydrogen from
C6, causing it to attack the same µ sulfur and closing the ureido ring to complete
biotin synthesis.285
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Figure 43: The BioB catalyzed reaction.
BioB is an unusual enzyme due to its two iron sulfur clusters and their very
different roles in catalysis. The [4Fe-4S]2+ is held by Cys53, Cys57, and Cys60 in a
canonical CXXCXXXC motif. The positioning of the [4Fe-4S]2+ cluster near the
surface of the protein at the end of the beta barrel probably makes it easier for
ferredoxin reductase to reduce the cofactor for reactivation.281 The [2Fe-2S]2+
cluster is coordinated by Cys97, Cys128, Cys188, and notably Arg260.281 The
three cysteines are well conserved, with serine or aspartate replacing Cys97, or
alanine replacing Cys128 in a minority of examined genomes. The deprotonated
Arg260288 is a particularly curious residue because it is perfectly conserved in all
of the examined sequences, but its importance to the protein’s activity remains a
mystery. The residue can be mutated to alanine, cysteine, histidine, and
methionine without destroying the enzymes activity, making it difficult to
determine why this position is so tightly conserved.286,289
Outside of the iron sulfur clusters, Asn151, Asn153, and Asn222 have been
identified as forming hydrogen bonds with the substrate. Asn153 appears to be
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particularly important in binding to the 9-mercapto DTB 72 intermediate, as
mutants at this position allow the intermediate to dissociate from the protein
before the second SAM can abstract the hydrogen to close the cycle.287,290 Asn153
and Asp155 have been identified as important in binding and coordinating
SAM.280,290
The mechanism by which the [2Fe-2S] cluster is regenerated after removal of
the sulfur has yet to be definitively determined. The most likely pathway at the
moment is that the ATP dependent chaperone HscA unfolds the protein so that
the cluster can be replaced by other proteins in the ISC system. It has been
demonstrated that HscA increases the number of BioB reaction turnovers, and
binds more tightly to the [2Fe-2S] cluster depleted form of the protein than to the
holoprotein.291 This would appear to be a very energetically inefficient way to
produce biotin.67 Although IscU mutants have demonstrated that a redundant
iron sulfur cluster regenerating pathway exists to regenerate BioB,291 no
mechanism of BioB regeneration has experimental support. Considering the very
small quantities of biotin 67 required by the cell, it may be more energy efficient
to completely unfold the protein with the ISC system than it would be to maintain
an additional protein to specifically regenerate BioB.
9.4 Thiolactomycin
Thiolactomycin 68 is a PKS derived product produced by members of the
Nocardia and Streptomyces genus that inhibits type II fatty acid synthases by
binding the malonyl-ACP pocket in FabB.292,293 Despite its structure being
determined in 1989294 and strong evidence published in 2003 of it being produced
by a PKS,292 no gene cluster was identified until 2015.295 The core of the product
is produced as would be expected from an acetate and three methylmalonates,
however the proposed mechanism of sulfur incorporation and cyclization, if
correct, is an unusual process (fig 44).
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Figure 44: Hypothetical thiolactomycin cyclization.
Radiolabeling has demonstrated that cysteine is the sulfur source.292 This is
supported by the presence of an NRPS component of TlmB which appears to
accept cysteine even though all carbons are accounted for from the PKS
components of the pathway. These NRPS modules probably allow for TlmS, a
cysteine desulfurase, to transfer the thiol group to TlmH, which has homology
with tRNA-specific 2-thiouridylases. Activation of the thiolation site is proposed
to occur by the formation of an epoxide rind by the P450 TlmD1. Knock out
experiments determined that TlmD1 is required for product formation even
though tall oxygens or oxidations in the core structure are accounted for by the
PKS modules. It has been proposed that the epoxide ring is replaced by a thiirane
ring by two subsequent nucleophilic attacks. The sulfur may then perform one




We are entering the era of big data when it comes to biology. Next generation
sequencing and high throughput systems give us more information than any
human being could possibly comprehend. Global databases of research do not just
report findings, they are rich sources of research themselves as scientists search
through their content for patterns that further our understanding of biology
without growing a single cell. With so much information at our fingertips it is easy
to forget how much in vitro and in vivo work remains to be done. This review has
shown how identical chemical moieties can be produced by very different chemical
pathways, as well as how similar chemical structures can serve very different
purposes in biology. More research is necessary on these understudied moieties
before the true power of computational biology can be brought to bear on these
pathways. Not just for the academic value of knowing how biology works, but to
expand the tool kit available to use that biology for our collective benefit.
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